Genetic Signatures Seeks CE Mark for Coronavirus Diagnostic

March 31, 2020

Australian PCR test developer Genetic Signatures has submitted a CE Mark certification application for its EasyScreen SARS-CoV-2 detection test.

The company said it anticipates high-volume orders for the product and has already primed European and Australian laboratories on the new test.

Genetic Signatures said that the assay can produce results for up to 188 patient samples in approximately 4.5 hours.

View today's stories